...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: I have opportunity to buy some

Hi,

I have an opportunity to buy some common shares. Last round was in August at 2.00 USD per unit (1 common share plus 1/2 warrant).

Anyone care to offer an opinion on the current value of the common shares (or the warrants)?

-Michael

Share
New Message
Please login to post a reply